Phase 1 Study to Determine the Safety and Dosing of Autologous PBMCs Modified to Present HPV16 Antigens (SQZ- PBMC-HPV) in HLA-A*02+ Patients with HPV16+ Solid Tumors
Investigational New Drugs(2023)
Key words
Cellular therapy,HPV16,Antigen presenting cell,Immunotherapy,Cancer vaccine
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined